The Environmental Determinants of Islet Autoimmunity (ENDIA) study is a national longitudinal prospective cohort study which aims to identify the environmental factors that drive the development of type 1 diabetes (T1D) in at-risk individuals.1 Recruitment commenced in 2013 and is proceeding at eight hospitals across Adelaide, Sydney, Melbourne, Brisbane, Perth and Geelong, covering approximately 64% of the general population.2 In 2016, ENDIA launched the Regional Participation Program (RPP) to facilitate the participation of eligible families outside these cities.
The full article is accessible to AMA
members and paid subscribers.
Login to MJA or subscribe now.
- 1. Penno MAS, Couper JJ, Craig ME, et al. Environmental determinants of islet autoimmunity (ENDIA): a pregnancy to early life cohort study in children at-risk of type 1 diabetes. BMC Pediatrics 2013; 13: 124.
- 2. Australian Bureau of Statistics [website]. Regional population growth, Australia, 2014–15 (Cat. No. 3218.0). Canberra: ABS; 2016. http://www.abs.gov.au/AUSSTATS/abs@.nsf/mf/3218.0 (accessed May 2016).
Online responses are no longer available. Please refer to our instructions for authors page for more information.
This research is supported by JDRF Australia (recipient of the Australian Research Council Special Research Initiative in Type 1 Juvenile Diabetes), the Helmsley Charitable Trust, JDRF International and the National Health and Medical Research Council (ACTRN1261300794707). On behalf of the ENDIA study team, we thank the participants and their families and the contributing institutions, which are listed at .